Excellent Hair Fall Treatment
Search: Look for:   Last 1 Month   Last 6 Months   All time

Now, 'nanoparticle-based' vaccines to boost immunity where it counts

London, Mon, 23 Jan 2012 ANI

London, Jan 23 (ANI): Synthetic nanoparticles that target lymph nodes, where the most effective immune reactions occur, could greatly boost vaccine responses, researchers say.

 

Currently all other adjuvants (substances added to vaccines to help to boost the immune response) are thought to enhance immunity at the skin site where the vaccine is injected rather than going to the lymph nodes.

 

The current study by researchers at Duke University Medical Center used mice to show it is possible to shift the delivery path directly to the lymph nodes.

 

The researchers based their strategy on their observation that mast cells, which are cells that are found in the skin that fight infections, also communicate directly to the lymph nodes by releasing nanoparticles called granules.

 

"Our strategy is unique because we have based our bioengineered particles on those naturally produced by mast cells, which effectively solve the same problem we are trying to solve of combating infection," said St. John, who is in the Duke-NUS Program in Emerging Infectious Diseases.

 

The synthetic granules consist of a carbohydrate backbone that holds tiny, encapsulated inflammatory mediators such as tumour necrosis factor (TNF). These particles, when injected, mimic the attributes of the granules found in natural cells, and the synthetic particles also target the draining lymph nodes and provide for the timed release of the encapsulated material.

 

Traditional vaccine adjuvants may help antigens (the small part of a pathogen that is injected during vaccination that the body reacts to) to persist so the body can have an immune reaction and build antibodies so that when a real pathogen, such as the flu virus arrives, it will be conquered.

 

Alternatively, adjuvants may activate cells called dendritic cells, which pick up pathogen parts and must travel from the skin to lymph nodes where immune reactions are initiated.

 

The Duke team, however, has created a vaccine adjuvant of nanoparticles that are capable of travelling from the point of injection to the lymph nodes where they act on many cell types of the immune system to spur the right reaction for a greatly increased immune response.

 

The researchers found that they could use this adjuvant in vaccinations of mice with the influenza A virus.

 

In levels of flu virus exposure that would be lethal in typical mice, the vaccinated mice were able to fight off the disease and had an increased survival rate, thanks to the effective immune response the particles stimulated.

 

The researchers also showed they could load the same type of particles with a different immune factor, IL-12, that directed a response toward a different set of lymphocytes.

 

This is an important finding since certain types of infections require specialized responses to be overpowered by the body.

 

St. John said the flexibility of the synthetic particles and their ability to target certain lymph nodes represented a new avenue of personalized medical treatment - personalized vaccines.

 

Senior author Soman Abraham, Ph.D., professor of pathology, immunology and molecular genetics and microbiology at Duke in Durham, N.C., and emerging infectious diseases at Duke-NUS, is cautiously optimistic that the mast-cell-inspired synthetic particles could make their way into human use soon.

 

The study has been published online in the journal Nature Materials. (ANI)

 


LATEST IMAGES
Haryana CM Manohar Lal congratulate former Deputy PM Lal Krishna Advani on his 92nd birthday
King of Bhutan, the Bhutan Queen and Crown Prince meeting the PM Modi
PM Narendra Modi welcomes the King of Bhutan
PM Modi paying tributes at the portrait of Sardar Vallabhbhai Patel
People take part in the Run For Unity on the Rashtriya Ekta Diwas
Post comments:
Your Name (*) :
Your Email :
Your Phone :
Your Comment (*):
  Reload Image
 
 

Comments:


 

OTHER TOP STORIES


Excellent Hair Fall Treatment
Careers | Privacy Policy | Feedback | About Us | Contact Us | | Latest News
Copyright © 2015 NEWS TRACK India All rights reserved.